News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Radiation Oncology|
Surgery
Advertisement

Andrés Cervantes, MD, PhD

Advertisement

Articles by Andrés Cervantes, MD, PhD

UFT Plus or Minus Calcium Folinate for Metastatic Colorectal Cancer in Older Patients

ByEduardo Diaz-rubio, MD, PhD,Javier Sastre, MD, PhD,Albert Abad, MD, PhD,Matilde Navarro, MD,Enrique Aranda, MD, PhD,Alfredo Carrato, MD, PhD,Manuel Gallén, MD,Eugenio Marcuello, MD,Julio Rifá, MD,Tomeu Massuti, MD,Andrés Cervantes, MD, PhD,Antonio Antón, MD, PhD,Carlos Fernandez-martos, MD
July 1st 1999

Two studies were carried out to determine the activity and evaluate the toxicity of oral chemotherapy with uracil and tegafur in a 4:1 molar ratio (UFT) plus or minus calcium folinate in elderly patients with advanced colorectal

Advertisement

Latest Updated Articles

  • UFT Plus or Minus Calcium Folinate for Metastatic Colorectal Cancer in Older Patients
    UFT Plus or Minus Calcium Folinate for Metastatic Colorectal Cancer in Older Patients

    July 1st 1999



Advertisement
Advertisement

Trending on CancerNetwork

1

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

2

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

3

Zenocutuzumab Earns FDA National Priority Voucher in Cholangiocarcinoma

4

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

5

Cevostamab May Fill Gap in Multiple Myeloma Armamentarium

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us